Qualcomm and Arm returned to a Delaware courtroom Monday in a case that could determine whether one of Arm’s biggest customers can stop paying billions of dollars in royalties for up to five years.
Qualcomm accuses Arm of withholding chip-testing tools required under their contracts and leaking a 2024 threat to terminate a key license, which Qualcomm says damaged negotiations for a potential chip deal with Meta Platforms. Arm denies breaching the agreements and argues that Qualcomm has not shown actual damages.
The dispute lands at a sensitive moment for AI chips, as Arm, AMD, Broadcom and Qualcomm all push deeper into data centers, PCs and custom silicon.
Qualcomm Wants Up to Five Years of Royalty Relief
The biggest financial issue is Qualcomm’s proposed remedy.
Qualcomm wants the right to suspend royalty payments to Arm for as long as five years. That could potentially be worth billions, given how central Arm licensing is to Qualcomm’s processor business.
The court is considering whether that remedy should remain available, making the case much more significant than a standard contract dispute.
The stakes are rising as Qualcomm expands beyond smartphones into PCs and data-center computing, where the broader AI infrastructure boom is creating new opportunities for processor and networking companies.
Nuvia and Meta Sit at the Center of the Fight
The relationship deteriorated after Qualcomm acquired CPU startup Nuvia for $1.4 billion in 2021.
Nuvia had developed custom processor technology under its own Arm architecture license. Arm later argued that Qualcomm could not simply transfer those rights after the acquisition and sued in 2022.
A Delaware jury rejected Arm’s central claim in 2024, but the dispute continued through appeals and new contract allegations.
The current case also involves Meta. Qualcomm says Arm leaked its license-termination threat while Qualcomm was negotiating a potential chip deal with Meta, harming those talks. Arm disputes that allegation and has countered with claims that Qualcomm disclosed confidential information involving antitrust probes.
Why the Case Matters for Chip Stocks
The outcome could affect more than damages.
Any ruling that changes royalty obligations or access to future Arm designs could alter the economics of Qualcomm’s expansion into AI and data centers, while also affecting Arm’s licensing model.
That matters as Arm participates in the wider chip rally alongside Nvidia, AMD and other semiconductor names.
